Diana Xing

Biomarker Lead @Boehringer Ingelheim

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2020 — Present

Biomarker Lead @Boehringer Ingelheim

View department →

EDUCATION

N/A

University at Albany

Ph. D., Immunology

N/A

Fudan University

Bachelor of Science (BS)

N/A

Harvard Medical School

Postdoctoral fellow

SKILLS

AntibodiesDrug DiscoveryCell BiologyCar-T Therapy, Nk Cell TherapyLife SciencesCell TherapyClinical DevelopmentWestern BlottingMethods and Compositions Related to Th-1 Dendritic Cells Us 8728806 B2Molecular BiologyCancerNegotiationIn VivoImmunologyOncologyCell Gene TherapyAnimal ModelsBiochemistryCell CultureVaccinesCellGmpIn Vitro

ABOUT DIANA XING

Motivated scientist and team leader with over 10 years’ experience in drug discovery and clinical development. In-depth knowledge of strategic, clinical and business of drug development. Extensive experience in T cell immune therapy in immune-oncology (CD19 CAR-T cell and TCR-T cell, Tumor infiltrated T cell, NK cell therapy, and dendritic cell therapy), autoimmune disease areas. Experience in both genomic and proteomic approaches in clinical biomarker design. Core expertise in translational research in immune-oncology, T cell immunotherapy. Knowledge in ICH, GMP, GCP, interaction with FDA, EMA. Excellent interpersonal and communication skills

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Diana Xing — Biomarker Lead at Boehringer Ingelheim in Cambridge, MA, US | Unifers